Terms: = Leukemia AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
10 results:
1. Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia.
Han Y; Hu A; Qu Y; Xu Q; Wang H; Feng Y; Hu Y; He L; Wu H; Wang X
Pharmacol Res; 2023 Mar; 189():106700. PubMed ID: 36796466
[TBL] [Abstract] [Full Text] [Related]
2. Expression of CD123 Related Long Non-coding RNA in Acute Myeloid leukemia Bone Marrow Mononuclear Cells and Its Clinical Significance.
Feng Y; Su B; Xu Y; He Y; He R; Ge F
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):140-147. PubMed ID: 36227664
[TBL] [Abstract] [Full Text] [Related]
3. FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.
Zhang YY; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Sun YQ; Liu KY; Huang XJ
Bone Marrow Transplant; 2019 Sep; 54(9):1462-1470. PubMed ID: 30710101
[TBL] [Abstract] [Full Text] [Related]
4. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
5. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
Kataoka K; Iwanaga M; Yasunaga JI; Nagata Y; Kitanaka A; Kameda T; Yoshimitsu M; Shiraishi Y; Sato-Otsubo A; Sanada M; Chiba K; Tanaka H; Ochi Y; Aoki K; Suzuki H; Shiozawa Y; Yoshizato T; Sato Y; Yoshida K; Nosaka K; Hishizawa M; Itonaga H; Imaizumi Y; Munakata W; Shide K; Kubuki Y; Hidaka T; Nakamaki T; Ishiyama K; Miyawaki S; Ishii R; Nureki O; Tobinai K; Miyazaki Y; Takaori-Kondo A; Shibata T; Miyano S; Ishitsuka K; Utsunomiya A; Shimoda K; Matsuoka M; Watanabe T; Ogawa S
Blood; 2018 Jan; 131(2):215-225. PubMed ID: 29084771
[TBL] [Abstract] [Full Text] [Related]
6. [Effects of DNMT3A gene mutations on prognosis of patients with acute myeloid leukemia: a meta-analysis].
Xi XP; Zeng LX; Yu FF; Liu HS
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 44(2):197-203. PubMed ID: 26038140
[TBL] [Abstract] [Full Text] [Related]
7. [Treatment of Ph-adult acute lymphoblastic leukemia patients with Tongji-96 regimen].
Ding Y; Li P; Zhang W; Wu H; Chen Y; Xiu B; Lu H; Li B; Fu J; Bo L; Liang A
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):272-6. PubMed ID: 25916284
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinoma.
Zhao P; Lu Y; Han W
Cancer Sci; 2010 Oct; 101(10):2262-8. PubMed ID: 20649898
[TBL] [Abstract] [Full Text] [Related]
9. [Expression of midkine in patients with acute myeloid leukemia and its significance].
Yang L; Dong ZR; Pan L; Luo JM; Xu SR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):442-5. PubMed ID: 16800916
[TBL] [Abstract] [Full Text] [Related]
10. Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome.
Mielcarek M; Sperling C; Schrappe M; Meyer U; Riehm H; Ludwig WD
Br J Haematol; 1997 Feb; 96(2):301-7. PubMed ID: 9029017
[TBL] [Abstract] [Full Text] [Related]
